Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1946 1
1951 1
1952 2
1953 2
1954 1
1955 3
1956 2
1957 2
1958 3
1959 3
1960 3
1961 3
1962 2
1963 3
1964 5
1965 3
1966 4
1967 4
1968 3
1969 2
1970 2
1971 4
1972 2
1973 4
1974 2
1975 16
1976 15
1977 11
1978 15
1979 21
1980 19
1981 13
1982 16
1983 20
1984 27
1985 41
1986 46
1987 47
1988 67
1989 71
1990 80
1991 79
1992 84
1993 106
1994 102
1995 86
1996 90
1997 129
1998 113
1999 127
2000 156
2001 178
2002 157
2003 183
2004 202
2005 257
2006 286
2007 357
2008 386
2009 445
2010 596
2011 716
2012 760
2013 898
2014 947
2015 967
2016 1115
2017 1205
2018 1393
2019 1593
2020 1978
2021 2254
2022 2229
2023 2254
2024 2380
2025 2445
2026 938

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,574 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean pharma a[au] (5 results)?
CerS2 is a druggable target in triple-negative breast cancer.
Alatawi H, Nair HH, Ai L, Mahmud I, Gour A, Singh A, Baek D, Yan B, Maharjan CK, Zhang W, Law BK, Zajac-Kaye M, Vulpe CD, Guryanova OA, Sharma AK, Garrett TJ, Sharma A, Heldermon CD, Hong S, Narayan S. Alatawi H, et al. Among authors: sharma a, sharma ak. Mol Cancer Ther. 2026 Apr 21. doi: 10.1158/1535-7163.MCT-25-1159. Online ahead of print. Mol Cancer Ther. 2026. PMID: 42012500
Patient profiles and disease characteristics of the IMSRN cohort: a multicentre study (2021-2025).
Bhatia R, Khurana D, Vasantha Padma Srivastava M, Garg A, Mohapatra P, Netravathi M, Nair S, Kanti Ray B, Thirumal Appaswamy P, Singh G, Krishnan M, Mathew T, Pandit L, Asimi R, Panda S, Chowdhury D, Banerjee TK, Kumar Nanda S, Sharma A, Kumar M, Kushwaha S, Prasad Gorthi S, Mahajan M, Sarmah B, Pardasani V, Saluja A, Saxena R, Haldar P, Longkumer I, Sharma M; IMSRN Collaborators. Bhatia R, et al. Among authors: sharma a. Lancet Reg Health Southeast Asia. 2026 Apr 10;48:100762. doi: 10.1016/j.lansea.2026.100762. eCollection 2026 May. Lancet Reg Health Southeast Asia. 2026. PMID: 42011245 Free PMC article.
25,574 results
You have reached the last available page of results. Please see the User Guide for more information.